glycine has been researched along with Bladder Cancer in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In muraglitazar-treated rats fed an acidified diet, urine pH was invariably < 6." | 5.33 | Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action. ( Arnold, LE; Cano, M; Cohen, SM; Dominick, MA; Moehlenkamp, JD; Sanderson, TP; Schilling, BE; Tannehill-Gregg, S; Van Vleet, T; Waites, CR; White, MR, 2006) |
| "Clinicians and patients with type 2 diabetes enjoy an expanding list of medications to improve glycemic control." | 2.50 | Systematic reviews to ascertain the safety of diabetes medications. ( Brito, JP; Gionfriddo, MR; Leppin, AL; Montori, VM; Morey-Vargas, OL; Murad, MH, 2014) |
| "In muraglitazar-treated rats fed an acidified diet, urine pH was invariably < 6." | 1.33 | Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action. ( Arnold, LE; Cano, M; Cohen, SM; Dominick, MA; Moehlenkamp, JD; Sanderson, TP; Schilling, BE; Tannehill-Gregg, S; Van Vleet, T; Waites, CR; White, MR, 2006) |
| " Attempts to determine whether increased exposure of urinary bladder to high concentrations of OA will influence bladder tumorigenesis revealed that chronic administration of glycine (2." | 1.27 | Effect of glycine on the induction of orotic aciduria and urinary bladder tumorigenesis in the rat. ( Abanobi, SE; Laconi, E; Rajalakshmi, S; Rao, PM; Sarma, DS; Vasudevan, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, A | 1 |
| Asano, T | 2 |
| Okubo, K | 1 |
| Isono, M | 1 |
| Kouznetsova, VL | 1 |
| Kim, E | 1 |
| Romm, EL | 1 |
| Zhu, A | 1 |
| Tsigelny, IF | 1 |
| Gionfriddo, MR | 1 |
| Morey-Vargas, OL | 1 |
| Brito, JP | 1 |
| Leppin, AL | 1 |
| Murad, MH | 1 |
| Montori, VM | 1 |
| Ye, P | 1 |
| Mimura, J | 1 |
| Okada, T | 1 |
| Sato, H | 1 |
| Liu, T | 1 |
| Maruyama, A | 1 |
| Ohyama, C | 1 |
| Itoh, K | 1 |
| Atkins, H | 1 |
| Davies, BR | 1 |
| Kirby, JA | 1 |
| Kelly, JD | 1 |
| Saga, Y | 1 |
| Hashimoto, H | 1 |
| Yachiku, S | 1 |
| Iwata, T | 1 |
| Tokumitsu, M | 1 |
| Hernández, S | 1 |
| López-Knowles, E | 1 |
| Lloreta, J | 1 |
| Kogevinas, M | 1 |
| Amorós, A | 1 |
| Tardón, A | 1 |
| Carrato, A | 1 |
| Serra, C | 1 |
| Malats, N | 1 |
| Real, FX | 1 |
| Dominick, MA | 1 |
| White, MR | 1 |
| Sanderson, TP | 1 |
| Van Vleet, T | 1 |
| Cohen, SM | 1 |
| Arnold, LE | 1 |
| Cano, M | 1 |
| Tannehill-Gregg, S | 1 |
| Moehlenkamp, JD | 1 |
| Waites, CR | 1 |
| Schilling, BE | 1 |
| Keshtkar, A | 2 |
| Mesbahi, A | 1 |
| Mehnati, P | 1 |
| Wallace, DM | 1 |
| Smith, JH | 1 |
| Billington, S | 1 |
| Smith, MR | 1 |
| Stemplewski, HE | 1 |
| Tipton, PW | 1 |
| Hahn, RG | 1 |
| Satoh, M | 2 |
| Cherian, MG | 2 |
| Imura, N | 2 |
| Shimizu, H | 1 |
| Kloth, DM | 1 |
| Kadhim, SA | 1 |
| Chin, JL | 1 |
| Naganuma, A | 1 |
| Rabbani, F | 1 |
| Richon, VM | 1 |
| Orlow, I | 1 |
| Lu, ML | 1 |
| Drobnjak, M | 1 |
| Dudas, M | 1 |
| Charytonowicz, E | 1 |
| Dalbagni, G | 1 |
| Cordon-Cardo, C | 1 |
| Marklová, E | 1 |
| Vasudevan, S | 1 |
| Laconi, E | 1 |
| Abanobi, SE | 1 |
| Rao, PM | 1 |
| Rajalakshmi, S | 1 |
| Sarma, DS | 1 |
1 review available for glycine and Bladder Cancer
| Article | Year |
|---|---|
Systematic reviews to ascertain the safety of diabetes medications.
Topics: Acidosis, Lactic; Blood Glucose; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Female; Fractur | 2014 |
15 other studies available for glycine and Bladder Cancer
| Article | Year |
|---|---|
Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.
Topics: Acetylation; Antineoplastic Agents; Apoptosis; Boron Compounds; Cell Line, Tumor; Cyclin D1; Cyclin- | 2017 |
Recognition of early and late stages of bladder cancer using metabolites and machine learning.
Topics: Amino Acids; Area Under Curve; Biomarkers, Tumor; ErbB Receptors; Galactose; Glycine; Humans; Insuli | 2019 |
Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.
Topics: Activating Transcription Factor 4; Amino Acid Transport System y+; Antineoplastic Agents; Boronic Ac | 2014 |
Polarisation of a T-helper cell immune response by activation of dendritic cells with CpG-containing oligonucleotides: a potential therapeutic regime for bladder cancer immunotherapy.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Animals; Carcinoma, Transitional Cell; Cytokin | 2003 |
Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors.
Topics: Alkynes; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Cystathionine gamm | 2004 |
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Cysteine; Female; Glutamic Acid; Glycine; Humans; Leucine; | 2006 |
Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
Topics: Animals; Antimetabolites; Apoptosis; Area Under Curve; Bromodeoxyuridine; Calcium; Carcinogens; Cell | 2006 |
Surface fluids effects on the bladder tissue characterisation using electrical impedance spectroscopy.
Topics: Air; Biophysical Phenomena; Biophysics; Coloring Agents; Cystoscopy; Electric Impedance; Glycine; Hu | 2008 |
Promotion of bladder tumours by endoscopic procedures in an animal model.
Topics: Animals; Catheterization; Cystoscopy; Diathermy; Female; Glycine; Inflammation; Methylnitrosourea; O | 1984 |
Transurethral resection syndrome after transurethral resection of bladder tumours.
Topics: Abdominal Pain; Absorption; Aged; Aged, 80 and over; Ethanol; Extravasation of Diagnostic and Therap | 1995 |
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibr | 1994 |
Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Cystathionine gamma-Lyase; Drug Resistance; Female; Glutathione; Glycin | 1993 |
Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization.
Topics: Carcinoma; Carrier Proteins; Cell Cycle Proteins; DNA-Binding Proteins; E2F Transcription Factors; E | 1999 |
Where does indolylacrylic acid come from?
Topics: Aging; Burns; Diet; Glycine; Humans; Indoles; Muscular Dystrophies; Skin Diseases; Tryptophan; Urina | 1999 |
Effect of glycine on the induction of orotic aciduria and urinary bladder tumorigenesis in the rat.
Topics: Ammonium Chloride; Animals; Aspartic Acid; Cycloheximide; Glycine; Isoxazoles; Male; Orotic Acid; Ra | 1987 |